GPhC registered|Tracked Delivery
Caremacy
Clinician-led

Weight loss,made simple.

Short online consultation. UK pharmacist reviews every case. Evidence-based treatment prescribed if it's clinically right for you.

  • UK-licensed, pharmacist-reviewed
  • Message your pharmacist directly, any time
  • Pause or cancel any time
Start your consultation
Pharmacist review
24h

Pharmacist review

Cold-chain delivery
Tracked

Cold-chain delivery

Registered pharmacy
GPhC

Registered pharmacy

Where to start

Weight-management treatments suited to you

Start where you are. A UK pharmacist takes it from there.

  • Stuck at a plateau

    Diet and exercise aren't shifting it anymore.

    Stuck at a plateau
    Get started

  • Cycle of regain

    Losing weight then putting it back on.

    Cycle of regain
    Get started

  • Health-driven

    A doctor's flagged it, or you want to prevent issues.

    Health-driven
    Get started

  • Not sure you qualify

    We'll tell you honestly — without judgement.

    Not sure you qualify
    Get started
Why Caremacy

Built around what patients actually need

Every prescription receives individual clinical review. Every treatment is UK-licensed. Every step is controllable from your dashboard.

Verified authenticity

UK-licensed Mounjaro and Wegovy, with every prescription checked through individual clinical review.

Side-effect support

Log symptoms on your dashboard or message a pharmacist directly as your body adjusts.

Total control

Pause or cancel any time from your dashboard. No phone calls, no awkward conversations.

Progress & refills

Track your progress on your dashboard. One-tap refill requests delivered to your door.

Your dashboard

Your digital health dashboard

Everything you need, in one place — the moment you sign in.

  • Chat

    Message a pharmacist directly

  • Track

    Log progress and symptoms

  • Report

    Instant side-effect logging

  • Manage

    Refills, pauses, cancellations

Treatments

Evidence-based treatments for weight management

All treatments are prescription-only. Your pharmacist decides which (if any) is clinically right for you during your consultation.

Wegovy

Semaglutide

Once-weekly GLP-1 injection. Prescribed in UK pharmacy with years of real-world safety data.

From£129/ month with Subscribe & Save
  • Once-weekly pen injection
  • GLP-1 hormone action
  • Refill request reviewed before every supply
  • Discreet, tracked cold-chain delivery
Check eligibilityLearn more

Mounjaro

Tirzepatide

Once-weekly dual-agonist (GLP-1 + GIP) injection. Targets two appetite pathways instead of one.

From£149/ month with Subscribe & Save
  • Once-weekly pen injection
  • Dual-action GLP-1 + GIP
  • Refill request reviewed before every supply
  • Discreet, tracked cold-chain delivery
Check eligibilityLearn more

Wegovy Tablets

Semaglutide (oral)

The first oral GLP-1 for weight loss — a once-daily tablet with the same active ingredient as Wegovy. No needles, no fridge.

From£85/ month with Subscribe & Save
  • Once-daily tablet — no injections
  • GLP-1 hormone action
  • Refill request reviewed before every supply
  • Discreet, tracked delivery — no cold chain
Check eligibilityLearn more

Foundayo

Orforglipron

The newest once-daily GLP-1 tablet (MHRA approved August 2026). No needles, no fridge, and no food or water rules — take it at any time of day.

From£99/ month with Subscribe & Save
  • Once-daily tablet — take at any time of day
  • No food or water restrictions
  • Refill request reviewed before every supply
  • Discreet, tracked delivery — no cold chain
Check eligibilityLearn more
How it works

Four steps. No waiting room.

From online assessment to discreet delivery — clinician-led, end to end.

  1. Share a few details

    Answer a short online questionnaire about your health, weight, and goals. Takes around three minutes.

  2. Pharmacist review

    A qualified prescriber reviews every case individually before any treatment is prescribed.

  3. Prescription

    If treatment is clinically right for you, your pharmacist prescribes and your dose is set individually.

  4. Delivery

    Treatment uses plain, temperature-controlled packaging with tracking. Available options and timings are confirmed before payment.

Eligibility

Is this programme right for you?

Usually suitable for

  • Adults (18+) with BMI ≥ 30, or ≥ 27 with a weight-related condition
  • Patients who have attempted lifestyle-led weight management without sustained effect
  • Patients able to take a once-weekly injection or a once-daily tablet
  • Patients willing to attend follow-up pharmacist reviews as part of the programme

Not suitable if you are / have

  • Pregnancy, planning pregnancy, or breastfeeding
  • Personal or family history of medullary thyroid carcinoma (MTC) or MEN 2 syndrome
  • Active severe gastrointestinal disease (e.g. gastroparesis, severe IBD)
  • History of acute pancreatitis
  • Type 1 diabetes (off-label for weight management)
  • Age under 18 years

This is a summary, not a complete assessment. A pharmacist reviews your full health history during consultation before any prescription is issued.

The science

How modern weight management actually works

These treatments work with your body's natural hormones — not against your willpower.

  1. Regulates appetite

    GLP-1 treatments mimic a natural gut hormone that tells your brain you're full, reducing hunger and cravings throughout the day.

  2. Slows digestion

    Food stays in your stomach longer, so you feel satisfied on smaller portions and blood sugar rises more gradually after meals.

  3. Supports long-term change

    Alongside nutrition and lifestyle adjustments, treatment helps the body adjust to healthier habits over time — under pharmacist supervision.

Compare treatments

Wegovy, Mounjaro or a daily tablet?

All are evidence-based GLP-1 treatments. Your pharmacist will recommend the right one based on your clinical history — not marketing.

Side-by-side comparison of Wegovy and Mounjaro and Wegovy Tablets and Foundayo
 WegovyMounjaroWegovy TabletsFoundayo
Active ingredientSemaglutideTirzepatideSemaglutide (oral)Orforglipron
Drug classGLP-1 agonistDual GLP-1 / GIP agonistGLP-1 agonistGLP-1 agonist (non-peptide)
FormulationOnce-weekly penOnce-weekly penOnce-daily tabletOnce-daily tablet
ManufacturerNovo NordiskEli LillyNovo NordiskEli Lilly
Starting dose0.25 mg2.5 mg1.5 mg0.8 mg
Pivotal trialSTEP-1 (NEJM 2021)SURMOUNT-1 (NEJM 2022)OASIS programme (NEJM 2025)ATTAIN-1 (NEJM 2025)
StorageFridge (cold chain)Fridge (cold chain)Room temperatureRoom temperature
Clinical evidence

What the trial data shows

Peer-reviewed evidence for each treatment, cited and attributed — not reframed as a personal promise.

Randomised controlled trial

STEP-1

Wilding JPH et al., NEJM 2021;384:989–1002

Participants
1,961
Duration
68 weeks
Comparator
Semaglutide vs. placebo, alongside lifestyle intervention

Participants on semaglutide 2.4 mg weekly lost an average of ~14.9% of baseline body weight versus ~2.4% on placebo. Trial participants had BMI ≥ 30, or ≥ 27 with a weight-related comorbidity.

Read the full paper

Randomised controlled trial

SURMOUNT-1

Jastreboff AM et al., NEJM 2022;387:205–216

Participants
2,539
Duration
72 weeks
Comparator
Tirzepatide vs. placebo, alongside lifestyle intervention

At the highest dose (15 mg), participants lost an average of ~22.5% of baseline body weight versus ~3% on placebo. Trial participants had BMI ≥ 30, or ≥ 27 with a weight-related comorbidity.

Read the full paper

Randomised controlled trial

OASIS-4

OASIS-4 investigators, NEJM 2025

Participants
307
Duration
64 weeks
Comparator
Oral semaglutide 25 mg daily vs. placebo, alongside lifestyle intervention

Participants on oral semaglutide 25 mg once daily lost up to ~16.6% of baseline body weight versus ~2.7% on placebo (more conservative analyses estimated ~13.6%). Trial participants had BMI ≥ 30, or ≥ 27 with a weight-related comorbidity.

Read the full paper

Trial results do not predict individual outcomes. Your pharmacist will discuss realistic expectations during consultation.

UK Registered Pharmacists

Meet Your Clinical Team

Every prescription is reviewed by our UK-registered pharmacists who genuinely care about your wellbeing.

Younes Mekhalfia

Younes Mekhalfia

Independent Prescribing Pharmacist

MPharm, IP10+ years experience
GPhC: 2085251
Aans Memon

Aans Memon

Prescribing Pharmacist

MPharm, IP10+ years experience
GPhC: 2085817

Video Message Reviews

Receive personalized video explanations with every prescription

Proactive Check-ins

We follow up to ensure your treatment is working for you

Side-effect Management

Direct pharmacist support if you experience any concerns

GPhC
All pharmacists registered with the General Pharmaceutical Council
Frequently asked questions

Everything you need to know about weight management

Common patient questions — grouped by category and answered with clinically reviewed guidance.

How does the weight management programme work?

You complete a short online questionnaire, a qualified prescriber reviews your case, and — if treatment is clinically appropriate — a prescription is issued. The programme combines medication, where appropriate, with ongoing clinical monitoring.

What treatments are used for weight management?

Caremacy prescribes UK-licensed GLP-1 treatments such as semaglutide and tirzepatide for eligible patients. These are once-weekly injections that work with natural appetite-regulating hormones. Your pharmacist will recommend the right option — or recommend against treatment — based on your individual clinical profile.

How long does it take to start seeing changes?

Most patients notice reduced appetite within the first couple of weeks of starting treatment. Clinical response is tracked over weeks and months, and your pharmacist will discuss realistic expectations during your consultation. Individual response varies with starting weight, dose, and lifestyle.

What happens if I stop treatment?

Appetite typically returns to its previous level once treatment stops. Long-term weight management benefits from the lifestyle changes built during treatment — your pharmacist will discuss a maintenance plan if you decide to stop.

How is this different from the NHS route?

NHS access to modern weight-management treatments is limited and often requires specialist referral with a long waiting list. Caremacy offers private, pharmacist-led access with a 24-hour clinical review and direct messaging with a named pharmacist.

Your health shouldn’t wait.

Free consultation, pharmacist-reviewed, discreet delivery.

Start your consultation